Concepedia

Tetsuya Takata

TT

Statistics

Publications

5

Citations

278

H-Index

5

Active since

1999

Affiliations

Kyoto University(Current)

Taiho Pharmaceutical (Japan)

Tetsuya Takata is an author at Kyoto University specializing in oncology, molecular oncology, and medicine.

Publications per year

1999–2002

5

Publications

5

Clinical Significance of p21 Expression in Non–Small-Cell Lung Cancer

Tsuyoshi Shoji, Fumihiro Tanaka, Tetsuya Takata et al. · Journal of Clinical Oncology · 2002 · 100 citations · Full text

Medicine, Molecular Biology, Oncology +17

Prognostic Significance of Apoptotic Index in Completely Resected Non–Small-Cell Lung Cancer

Fumihiro Tanaka, Yozo Kawano, Mio Li et al. · Journal of Clinical Oncology · 1999 · 62 citations

Medicine, Oncology, Apoptosis +16

Clinical significance of caspase-3 expression in pathologic-stage I, nonsmall-cell lung cancer

Tetsuya Takata, Fumihiro Tanaka, Tomoko Yamada et al. · International Journal of Cancer · 2001 · 48 citations · Full text

Life Sciences, Oncology, Pathology +11

Prognostic value of thymidylate synthase expression in patients with p-stage I adenocarcinoma of the lung

Tatsuo Nakagawa, Fumihiro Tanaka, Yosuke Otake et al. · Lung Cancer · 2002 · 44 citations · Full text

Medicine, Cancer Biology, Oncology +13

Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p‐stage I nonsmall‐cell lung cancer

Tatsuo Nakagawa, Fumihiro Tanaka, Tetsuya Takata et al. · Journal of Surgical Oncology · 2002 · 24 citations

Medicine, Oncology, Pharmacology +13

1–5 of 5